Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × High Grade Serous Carcinoma × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 314 Neoplasms 234 Prostatic Neoplasms 183 Lung Neoplasms 141 Carcinoma, Non-Small-Cell Lung 119 Leukemia, Myeloid, Acute 110 Colorectal Neoplasms 103 Brain Neoplasms 85 Neoplasm Metastasis 79 Multiple Myeloma 73 Pancreatic Neoplasms 64 Melanoma 64 Glioma 62 Ovarian Neoplasms 61 Carcinoma, Hepatocellular 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 55 Glioblastoma 55 Uterine Cervical Neoplasms 52 Squamous Cell Carcinoma of Head and Neck 52 Head and Neck Neoplasms 51 Sarcoma 49 Recurrence 47 Urinary Bladder Neoplasms 46 Colonic Neoplasms 45 Myelodysplastic Syndromes 43 Hematologic Neoplasms 43 Triple Negative Breast Neoplasms 41 Carcinoma, Renal Cell 40 Lymphoma 39 Rectal Neoplasms 37

Interventions

olaparib 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03462342 2026-03-17

CAPRI

University of Pennsylvania

Phase 2 Completed

High Grade Serous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡